Aspirin and atherosclerosis

September 23, 2008

Appearing in the October issue of JLR

Aspirin has become one of the most widely used medications in the world, owing to its ability to reduce pain, fevers, inflammation, and blood clotting. In animal studies, aspirin has also been shown to prevent atherosclerosis, though none of its known mechanisms of action would seem to account for this. In a new study, though, researchers have uncovered the mechanism that may explain aspirin's ability to prevent arterial plaque buildup.

Using cell culture and mouse models, Sampath Parthasarathy and colleagues observed that aspirin -specifically its active byproduct salicylate- can greatly increase the expression of two proteins: paraoxonase 1 (PON1) and apolipoprotein A1 (ApoA1); in the mouse studies, low dose aspirin supplements could increase PON1 and ApoA1 levels by 7- and 12- fold, respectively.

Both of these proteins are beneficial components of the HDL complex, the "good cholesterol" that helps prevent atherosclerosis; ApoA1 removes bad cholesterol from the bloodstream while PON1 is an antioxidant that breaks down toxic lipid peroxides.

The researchers also noted that the heightened expression of PON1 was accompanied by an increase in a receptor called AHR (aryl hydrocarbon receptor); this was intriguing as a chemical known to attach to AHR is resveratrol, the "heart healthy" component of red wine.

American Society for Biochemistry and Molecular Biology

---

---

	Atherosclerosis by Sarah Jane George (Editor), Jason Johnson (Editor) Covering the most devastating disease in the Western world, this handbook and ready reference provides a comprehensive account of the different stages and factors in the development of the atherosclerotic plaque. Each chapter is written by experts in the field and highlights the role of specific mediators of atherosclerotic plaque development, as well as potential therapeutic targets. A large amount of this up-to-date information is conveyed by way of tables and schematic figures, in a readily comprehensible manner. A must-have for master and PhD students, researchers, MDs and lecturers in vascular biology and cardiology, as well as for academics and scientists in the pharmaceutical industry.
	Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment (Contemporary Cardiology) by Morteza Naghavi (Editor) Despite recent advances in the diagnosis and treatment of symptomatic atherosclerosis, available traditional screening methods for early detection and treatment of asymptomatic coronary artery disease are grossly insufficient and fail to identify the majority of victims prior to the onset of a life-threatening event. In Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment, Dr. Morteza Naghavi and leading authorities from the Society for Heart Attack Prevention and Eradication (SHAPE) present a new paradigm for the screening and primary prevention of asymptomatic atherosclerosis. The text focuses on accurate, yet underutilized, measures of subclinical atherosclerosis, notably coronary artery calcium scanning and carotid intima-media thickness measurement. The authors...
	Dyslipidemia and Atherosclerosis Essentials 2009 by Christie M. Ballantyne (Author), James H. O'Keefe Jr. (Author), Antonio M. Gotto Jr. (Author) The World's Leading Experts Provide all the 'Essentials' Needed to Manage Patients in the Office, on the Ward, and in the Intensive Care Unit! Written by key opinion leaders in the field of cardiology, Dyslipidemia Essentials integrates the latest clinical guidelines and trials into a practical step-by-step guide to the management of dyslipidemia. Important clinical trials, common management pitfalls, and other cardiovascular risk reduction measures are also emphasized. Topics include: Step-by-step guide to intensive LDL lowering; NCEP ATP III and AHA/ACC guideline Updates; Treatment of low HDL cholesterol and elevated triglyceride; 73 dyslipidemia trials and 17 drug summaries
	Atherosclerosis: Experimental Methods and Protocols (Methods in Molecular Medicine) by Angela F. Drew (Editor) In Atherosclerosis: Experimental Methods and Protocols, Angela Drew and a panel of experts have assembled a comprehensive collection of traditional and cutting-edge techniques for investigating this disease and its possible treatments. Each readily reproducible method includes step-by-step instructions and practical information regarding sample collection, the choice of animal model system, experimental design, and practical data analysis techniques. Comprehensive and richly detailed, Atherosclerosis: Experimental Methods and Protocols enables all biomedical investigators to select those optimized techniques that may be most fruitfully used to study the development, progression, and treatment of atherosclerotic lesions today.
	Inflammation and Atherosclerosis by Georg Wick (Editor), Cecilia Grundtman (Editor) It has been known for over 150 years that hallmarks of inflammation can be observed in the wall of atherosclerotic vessels. It was, however, not clear if this inflammation is the cause or the consequence of atherogenesis. More recently, it has become evident that inflammation mediated both by innate and adaptive immunity is instrumental even in the earliest stages of the development of atherosclerotic lesions, i.e., that it plays an important pathogenetic role. In this volume, international experts in the field discuss the pathogenetic, diagnostic, preventive and possible therapeutic relevance of inflammation in atherogenesis. This book is intended for researchers and physicians in the fields of vascular biology, immunology and atherosclerosis.
	Biochemistry of Atherosclerosis (Advances in Biochemistry in Health and Disease) by Sukhinder C. Kaur (Editor) This book covers many aspects of atherogenesis, with particular emphasis on lipid and lipoprotein metabolism. It includes all aspects of the regulation of cholesterol homeostasis and the importance of each pathway. Also explored are the roles of nuclear hormone receptors on lipid and lipoprotein metabolism and their complex roles in atherogenesis. The book further discusses how genetic studies can help understand the complexities that mediate these aspects of atherogenesis.
	CATHETER-BASED TREATMENT OF ATHEROSCLEROSIS: Options for effective percutaneous intervention are plentiful From the initial balloon catheters, percutaneous ... protection devices. (Postgraduate Medicine) by JTE Multimedia Hopes for successful utilization, minimal complications, and improved patient comfort ride on interventional cardiology. A variety of devices are available or in development for percutaneous treatment of atherosclerotic disease. Here, Dr Khalil reviews devices with a long history in cardiology as well as newer arrivals and discusses their best-use parameters and appropriate application. He also summarizes the outcome data on their use. Original Publication Date: March 2004
	C-REACTIVE PROTEIN AS A NOVEL BIOMARKER: Reactant can flag atherosclerosis and help predict cardiac events Exploring the role of this acute phase response ... disease. (Postgraduate Medicine) by JTE Multimedia C-reactive protein (CRP) is a relatively nonspecific marker of inflammation. However, it can be used to monitor the severity and progression of some well-defined cardiovascular diseases. For example, it can predict serious events in patients with coronary artery disease (CAD) who are hospitalized with acute coronary syndrome, myocardial infarction (MI), or advanced peripheral vascular disease. In this article, the authors review the role of CRP in the diagnosis, monitoring, and treatment of various forms of ischemic and inflammatory cardiovascular disease. Original Publication Date: December 2003
	Oophorectomy Increases Risk for Atherosclerosis.(Brief Article): An article from: Family Practice News by Doug Brunk (Author) This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2001. The length of the article is 348 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Oophorectomy Increases Risk for Atherosclerosis.(Brief Article) Author: Doug Brunk Publication: Family Practice News (Magazine/Journal) Date: February 1, 2001 Publisher: International Medical News Group Volume: 31 Issue: 3 Page: 25 Article Type: Brief Article Distributed by Thomson...
	Metabolic syndrome predicts subclinical atherosclerosis in adults.(Across Specialties): An article from: Clinical Psychiatry News by Bruce Jancin (Author) This digital document is an article from Clinical Psychiatry News, published by Thomson Gale on July 1, 2005. The length of the article is 539 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Metabolic syndrome predicts subclinical atherosclerosis in adults.(Across Specialties) Author: Bruce Jancin Publication: Clinical Psychiatry News (Magazine/Journal) Date: July 1, 2005 Publisher: Thomson Gale Volume: 33 Issue: 7 Page: 59(1) Distributed by Thomson...